Results•11 min read•Updated 2025-11-25

Tirzepatide Week 36: What to Expect, Weight Loss & Tips

Tirzepatide week 36 guide covering expected weight loss, side effects at the 15 mg (maintenance) dose, diet and exercise tips, and how your results compare to SURMOUNT trial data.

Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. This guide provides week-specific information for patients on tirzepatide therapy. Content is updated regularly to reflect the latest clinical evidence and patient outcomes.

Quick links: Tirzepatide treatment, semaglutide treatment, and tirzepatide weight loss results.

What Happens During Week 36 of Tirzepatide?

Week 36 completes nine months of tirzepatide therapy and represents a remarkable journey of health transformation. Cumulative weight loss of 55 to 60 or more pounds, representing 20 to 22.5 percent or more of starting body weight, matches the outcomes seen in the highest dose groups of the landmark SURMOUNT clinical trials. Looking ahead, the key focus is on maintaining these results through continued treatment, sustained lifestyle changes, and ongoing medical supervision.

At the 15 mg (maintenance) dose during the full dose maintenance, tirzepatide is maintaining its full therapeutic effect, supporting the long-term weight management and metabolic health improvements you have achieved. The medication works by mimicking both the GLP-1 and GIP hormones naturally produced in your gut, reducing hunger, slowing gastric emptying, and improving how your body processes glucose and stores fat.

If you are looking for information about week 35, visit that guide for week-specific details. For a complete overview of what tirzepatide can achieve, see our guide on how much weight you can lose on tirzepatide.

Expected Weight Loss at Week 36

By week 36 of tirzepatide treatment at the 15 mg (maintenance) dose, patients typically experience cumulative weight loss of 50-60+ lbs. This represents approximately 20-22.5% of starting body weight for most patients, though individual results can vary significantly based on factors including starting weight, metabolic rate, dietary adherence, physical activity level, and genetic factors that influence how your body responds to GLP-1 receptor agonist therapy.

The SURMOUNT-1 trial, published in the New England Journal of Medicine, demonstrated that tirzepatide at the 15 mg dose produced a mean weight loss of 22.5 percent of body weight over the full treatment period. Participants in the maintenance phase showed sustained weight loss with continued treatment. These results established tirzepatide as the most effective GLP-1 based weight loss medication available and demonstrated that long-term treatment maintains the weight loss achieved during the dose escalation phase.

Week 36 Weight Loss Snapshot

Dose: 15 mg (maintenance) | Typical cumulative loss: 50-60+ lbs | Body weight reduction: 20-22.5% | Phase: Full Dose Maintenance

For context on how these results compare to other GLP-1 medications, see our detailed tirzepatide vs semaglutide comparison. Tirzepatide consistently outperforms semaglutide in clinical trials due to its dual mechanism of action, and this advantage is evident even at week 36 of treatment.

Side Effects at Week 36

By the maintenance phase, most patients have developed excellent tolerance to tirzepatide. Side effects are minimal and predictable. Occasional mild nausea may occur, particularly after unusually large meals, but most patients describe their side effect profile as negligible. The medication has become a routine part of life rather than something that requires active management. Any new or worsening symptoms at this stage should be reported to your provider promptly.

Nausea: Generally mild and infrequent, usually triggered by eating too quickly or consuming high-fat foods

Appetite suppression: Strong and consistent, representing a fundamental shift in your hunger patterns

Gastrointestinal changes: Largely stabilized, with occasional mild episodes that are easily managed with dietary awareness

Fatigue: Occasional tiredness during periods of active weight loss, manageable with adequate sleep and nutrition

Hair changes: Some patients notice temporary hair thinning related to rapid weight loss rather than the medication itself

For a comprehensive overview of all potential side effects, read our complete guide on tirzepatide side effects. If you experience severe or persistent symptoms, contact your healthcare provider promptly.

Appetite and Food Changes at Week 36

Appetite at the maintenance dose has settled into a stable, sustainable pattern. Most patients eat regular, moderate meals without significant hunger between meals and without the constant food thoughts that characterized their pre-treatment lives. This normalized appetite is one of the key benefits patients hope to maintain long-term.

Understanding how tirzepatide affects your appetite is key to maximizing your results. Unlike stimulant-based weight loss medications that create jittery energy, tirzepatide works through your body's natural hormone signaling pathways. The GLP-1 receptor activation slows gastric emptying, making you feel fuller longer after meals, while the GIP receptor activation improves your body's ability to process nutrients efficiently. Together, these mechanisms create a sustainable reduction in caloric intake without the feeling of deprivation that characterizes most diets.

At week 36, many patients describe the reduction in food noise — that persistent mental chatter about what to eat, when to eat, and how much to eat — as essentially gone, replaced by a calm, rational approach to eating that feels natural and sustainable. This psychological benefit is often cited as one of the most transformative aspects of GLP-1 therapy.

Diet Tips for Week 36

As you transition to maintenance, focus on building sustainable eating habits that will serve you even if you eventually reduce your dose or discontinue the medication. Learn to cook nutritious meals you enjoy, develop a regular eating schedule, and practice mindful eating. The dietary patterns you establish now will be crucial for maintaining your weight loss in the years ahead. Ensure you are meeting all micronutrient needs through a balanced diet and supplementation as needed.

Prioritize protein at every meal — aim for at least 25 grams per meal to preserve lean muscle mass during weight loss

Eat slowly and mindfully, taking at least 20 minutes per meal to allow your brain to register fullness signals

Stay hydrated with at least 64 ounces of water daily, sipping throughout the day rather than drinking large amounts at once

Avoid high-fat fried foods and heavy sauces that can worsen nausea and gastrointestinal side effects

Include fiber-rich vegetables and whole grains to support digestive health and maintain regular bowel movements

Plan meals in advance to ensure you are eating nutritious foods even when appetite is low

For a deeper look at the complete GLP-1 treatment guide, including nutritional strategies optimized for patients on tirzepatide and semaglutide, visit our comprehensive resource. Proper nutrition significantly impacts both the rate and sustainability of your weight loss results.

Exercise Recommendations for Week 36

Exercise at this stage should focus on maintenance and enjoyment rather than purely weight loss. Find physical activities you genuinely love — hiking, dancing, swimming, sports, or group fitness. Consistent strength training remains critical for maintaining the muscle mass and metabolic rate you have built. Aim for a sustainable routine of 4 to 5 sessions per week that you can maintain indefinitely.

Physical activity during week 36 of tirzepatide treatment serves multiple purposes beyond accelerating weight loss. Regular exercise helps preserve lean muscle mass, which is critical during any period of significant weight reduction. Muscle preservation maintains your metabolic rate, improves body composition, and ensures that the weight you lose is predominantly fat rather than muscle tissue. Additionally, exercise improves cardiovascular health, enhances insulin sensitivity, boosts mood through endorphin release, and supports better sleep quality.

At this advanced stage of treatment, your exercise capacity has dramatically improved. Activities that seemed impossible at the start of treatment may now be part of your regular routine. Maintaining this exercise habit is crucial for long-term weight maintenance, regardless of whether you continue medication.

SURMOUNT Trial Data: Week 36 Context

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults with obesity or overweight with at least one weight-related comorbidity. Participants were randomized to receive tirzepatide at 5 mg, 10 mg, or 15 mg, or placebo. The trial ran for 72 weeks and demonstrated that all tirzepatide dose groups achieved statistically significant and clinically meaningful weight loss compared to placebo. The results established tirzepatide as the most effective GLP-1 based weight loss medication in clinical use.

At week 36, your results should be evaluated in the context of these clinical benchmarks. If your weight loss is tracking at or above the trial averages, you are responding well to treatment. If your results are below expectations, discuss with your provider whether dose adjustment, dietary modifications, or additional interventions might help optimize your outcome. For detailed tirzepatide weight loss results across all dose levels, see our comprehensive analysis.

Getting Tirzepatide at $125 Per Month

One of the biggest barriers to tirzepatide therapy is cost. Brand-name Zepbound and Mounjaro can cost over $1,000 per month without insurance. Trimi offers compounded tirzepatide starting at $125 per month, making this life-changing medication accessible to patients who might otherwise be unable to afford treatment.

Trimi's pricing includes the medication, provider consultations, ongoing medical oversight, and free shipping — no hidden fees, no consultation charges, and no long-term contracts. You can start, adjust, or cancel your treatment at any time. Every prescription is evaluated by board-certified providers who specialize in weight management and metabolic health, ensuring you receive expert guidance throughout your treatment journey.

For patients at week 36 who are considering starting treatment or switching providers, Trimi offers a straightforward path to affordable tirzepatide therapy. Visit our best GLP-1 provider guide to compare your options and find the right fit for your weight loss goals.

Tips for Success at Week 36

Focus on building sustainable habits that will maintain your results for years to come

Track your progress with weekly weigh-ins taken at the same time under the same conditions for accuracy

Take progress photos monthly — the mirror and scale do not always reflect the full extent of your transformation

Communicate openly with your provider about any side effects, concerns, or questions about your treatment plan

Connect with a community of other tirzepatide patients for support, motivation, and shared experience

Begin planning for long-term maintenance including discussions with your provider about sustained therapy

Manage stress through mindfulness, meditation, or therapy, as stress can trigger emotional eating even with appetite suppression

Frequently Asked Questions

How much weight should I lose by week 36 of tirzepatide?

By week 36 of tirzepatide treatment at the 15 mg (maintenance) dose, most patients have lost approximately 50-60+ lbs from their starting weight, which typically represents 20-22.5% of total body weight. Individual results vary based on starting weight, diet, exercise, and metabolic factors. The SURMOUNT clinical trials showed consistent weight loss at this stage of treatment, though some patients may lose more or less than the average.

What are the common side effects at week 36 on tirzepatide?

At week 36 on the 15 mg (maintenance) dose, common side effects include minimal and well-managed side effects, stabilized appetite, and long-term tolerability. Most patients find that side effects are well-controlled and significantly less disruptive than in earlier weeks. If you experience severe or persistent side effects, contact your healthcare provider for guidance on managing symptoms or adjusting your treatment plan.

Should I increase my tirzepatide dose after week 36?

Dose escalation decisions at week 36 should be made in consultation with your healthcare provider based on your individual response, side effect tolerance, and weight loss goals. At the higher doses, your provider will evaluate whether maintaining, reducing, or staying at your current dose is most appropriate. Never adjust your dose without medical guidance.

What should I eat during week 36 of tirzepatide?

During week 36 on tirzepatide, your nutritional strategy should emphasize quality and consistency. As you transition to maintenance, focus on building sustainable eating habits that will serve you even if you eventually reduce your dose or discontinue the medication. Learn to cook nutritious meals you enjoy, develop a regular eating schedule, and practice mindful eating. The dietary patterns you establish now will be crucial for maintaining your weight loss in the years ahead. Ensure you are meeting all micronutrient needs through a balanced diet and supplementation as needed. The reduced appetite caused by tirzepatide means every calorie counts more, so prioritize nutrient-dense whole foods including lean proteins, vegetables, fruits, and whole grains. Avoid high-fat and high-sugar processed foods which can worsen gastrointestinal side effects. Stay well-hydrated with at least 64 ounces of water daily, as proper hydration supports both weight loss and side effect management.

Is it normal to hit a weight loss plateau at week 36?

Plateaus become more common in the later stages of treatment as your body approaches a new equilibrium weight. A plateau lasting one to three weeks is normal and expected. If the plateau extends beyond three weeks, discuss with your provider whether a dose adjustment or modification to your diet and exercise plan might help restart progress.

Can I exercise during week 36 of tirzepatide treatment?

Absolutely. Exercise during week 36 of tirzepatide is encouraged and enhances your results. Exercise at this stage should focus on maintenance and enjoyment rather than purely weight loss. Find physical activities you genuinely love — hiking, dancing, swimming, sports, or group fitness. Consistent strength training remains critical for maintaining the muscle mass and metabolic rate you have built. Aim for a sustainable routine of 4 to 5 sessions per week that you can maintain indefinitely. Listen to your body and adjust intensity based on how you feel, especially on injection days when nausea may be more noticeable. Regular physical activity not only accelerates weight loss but also helps preserve lean muscle mass, improves cardiovascular health, boosts mood, and supports long-term weight maintenance after treatment.

How does week 36 on tirzepatide compare to semaglutide?

At week 36, tirzepatide typically produces greater weight loss than semaglutide at a comparable timepoint. Clinical trial data from the SURMOUNT trials for tirzepatide and the STEP trials for semaglutide show that tirzepatide patients lose approximately 20 to 25 percent more total body weight on average. This advantage comes from tirzepatide's dual mechanism of action, targeting both GLP-1 and GIP receptors, compared to semaglutide which targets only GLP-1. However, individual responses vary and some patients may respond better to one medication over the other.

Sources & References

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Individual results vary significantly based on starting weight, metabolic factors, diet, exercise, and medication adherence. Always consult a qualified healthcare provider before starting, adjusting, or discontinuing any medication. The weight loss figures cited are based on clinical trial averages and may not reflect your individual experience. Trimi provides compounded tirzepatide — this is not a review of brand-name Zepbound or Mounjaro.

Tirzepatide Week 36: What to Expect, Weight Loss & Tips

More on Tirzepatide Timeline

Tirzepatide Week 35

Tirzepatide Weight Loss Results

How Much Weight Can You Lose on Tirzepatide